Safety and Efficacy Study on Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease (PROTEGO-1 Study)
Clinical trial NCT05133180 · COMPLETED
Trial details
- NCT number
- NCT05133180
- Sponsor
- Dompé Farmaceutici S.p.A
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-19
- Primary completion
- 2022-09-22
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.